BE1003046A3 - Compositions veterinaires synergiquement actives et leur procede de preparation. - Google Patents

Compositions veterinaires synergiquement actives et leur procede de preparation. Download PDF

Info

Publication number
BE1003046A3
BE1003046A3 BE8900355A BE8900355A BE1003046A3 BE 1003046 A3 BE1003046 A3 BE 1003046A3 BE 8900355 A BE8900355 A BE 8900355A BE 8900355 A BE8900355 A BE 8900355A BE 1003046 A3 BE1003046 A3 BE 1003046A3
Authority
BE
Belgium
Prior art keywords
methyl
preparation
synergistically active
compositions
veterinary compositions
Prior art date
Application number
BE8900355A
Other languages
English (en)
Inventor
Karoly Magyar
Ferenc Simon
Janos Varga
Attila Nagy
Laszlo Puskas
Pal Fekete
Janos Egri
Suemeg Katalin Zukovics
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of BE1003046A3 publication Critical patent/BE1003046A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention est relative à des compositions vétérinaires synergiquement actives, utiles en particulier pour le traitement de la mastite et de la métrite. L'inventon se rapporte de plus à un procédé pour préparer ces compositions.Les compositions selon l'invention comprennent pour 1 partie en poids de 6,9,18-tris-(2-aminoéthyl)-15-benzyl-21-[2,8-bis-(2-aminoéthyl)-5-(1-hydroxyéthyl)-15-méthyl-4,7,10-trioxo-3,6,9-triazahepta-décanamido]-3-(1-hydroxyéthyl)-12-isobutyl-1,4,7,10,13,16,19-heptaazacyclotricosane-2,5,8,11,14,17,20-heptaone ou d'un sel de celle-ci acceptable du point de vue pharmaceutique, 1 à 1000 parties en poids de 1-(2-chlorophényl)-diphényl-méthyl-1H-imidazole ou 1 à 400 parties de 2-méthyl-5-7-dichloro-8-hydroxyquinoléine, respectivement, éventuellement en mélange avec des supports et/ou additifs couramment utilisés dans l'industrie pharmaceutique.
BE8900355A 1988-04-01 1989-03-31 Compositions veterinaires synergiquement actives et leur procede de preparation. BE1003046A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881606A HU199682B (en) 1988-04-01 1988-04-01 Process for producin synergetic veterinary composition

Publications (1)

Publication Number Publication Date
BE1003046A3 true BE1003046A3 (fr) 1991-11-05

Family

ID=10955291

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900355A BE1003046A3 (fr) 1988-04-01 1989-03-31 Compositions veterinaires synergiquement actives et leur procede de preparation.

Country Status (16)

Country Link
US (1) US5120711A (fr)
JP (1) JPH01305035A (fr)
KR (1) KR890015741A (fr)
AR (1) AR240400A1 (fr)
AU (1) AU608145B2 (fr)
BE (1) BE1003046A3 (fr)
CH (1) CH677608A5 (fr)
DE (1) DE3910743A1 (fr)
DK (1) DK158689A (fr)
FR (1) FR2629346B1 (fr)
GB (1) GB2216796B (fr)
HU (1) HU199682B (fr)
IL (1) IL89816A (fr)
IT (1) IT1229223B (fr)
NL (1) NL8900788A (fr)
NZ (1) NZ228559A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283005A (en) * 1992-10-08 1994-02-01 Olin Corporation Synergistic biocide combination for industrial fluids
US5696083A (en) * 1992-11-10 1997-12-09 Olin Corporation Personal care composition containing pyrithione and polymyxin
US5360788A (en) * 1992-11-10 1994-11-01 Olin Corporation Personal care composition containing pyrithione and a basic lipopeptide
US6600422B2 (en) 1996-10-29 2003-07-29 Joint Techno Concepts International, Inc. Apparatus and method for electronic exclusion and confinement of animals relative to a selected area
US6657544B2 (en) 1996-10-29 2003-12-02 Joint Techno Concepts International, Inc. Apparatus and method for electronic exclusion and confinement of animals relative to a selected area
WO2006077856A1 (fr) * 2005-01-19 2006-07-27 Nippon Zenyaku Kogyo Co., Ltd. Préparation pour injection contre la mastite
GB0813211D0 (en) * 2008-07-18 2008-08-27 E Therapeutics Plc Antibacterial combination therapy for the treatment of gram positive bacterial infections
CN109512999B (zh) * 2016-03-04 2022-05-10 广州英赛特生物技术有限公司 含氧碳氢衍生物的脂肪醇作为多粘菌素的协同增效剂的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695881A (en) * 1951-01-22 1954-11-30 Monsanto Chemicals Antiseptic soap composition
US3980778A (en) * 1973-10-25 1976-09-14 The Upjohn Company Anti-inflammatory steroid
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
GB1602745A (en) * 1977-10-13 1981-11-18 Squibb & Sons Inc Inhibiting growth of mycoplasmas
US4376787A (en) * 1979-12-03 1983-03-15 Economics Laboratory, Inc. Control of mastitis
US4600711A (en) * 1982-08-18 1986-07-15 The University Of Kentucky Research Foundation Composition for topical and infusion treatment of wounds and burns
BE902010A (fr) * 1984-03-28 1985-09-25 Hajdusagi Agraripari Egyesules Nouvelles combinaisons de medicaments ayant un effet synergique et procede pour les preparer.
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 106, no. 7, 16 février 1987, page 360, abrégé no. 47108p, Columbus, Ohio, US; C.A. MUCKLE et al.: "Susceptibility of Escherichia coli from bovine mastitis to new antimicrobial drugs", & CAN. J. VET. RES. 1986, 50(4), 543-4 *
CHEMICAL ABSTRACTS, vol. 109, no. 3, 18 juillet 1988, page 87, abrégé no. 17316z, Columbus, Ohio, US; GVANDEPUTTE-VAN MESSOM et al.: "Effect of bovine somatotrpoin on milk yield and composition during Eschericha coli-induced mastitis in lactating cows: some preliminary results", & VLAAMS DIERGENEESKD. TIJDSCHR. 1988, 57(1), 53-61 *
CHEMICAL ABSTRACTS, vol. 87, no. 7, 15 août 1977, page 74, abrégé no. 48477j, Columbus, Ohio, US; K. BELA: "Therapeutic value of gentamicin in the treatment of mastitis", & MAGY. ALLATORV. LAPJA 1977, 32(2), 131-3 *

Also Published As

Publication number Publication date
AU3234989A (en) 1989-10-05
NL8900788A (nl) 1989-11-01
HU199682B (en) 1990-03-28
CH677608A5 (fr) 1991-06-14
IL89816A (en) 1993-05-13
AU608145B2 (en) 1991-03-21
IL89816A0 (en) 1989-09-28
KR890015741A (ko) 1989-11-25
IT1229223B (it) 1991-07-26
IT8919975A0 (it) 1989-03-31
DK158689A (da) 1989-10-02
FR2629346A1 (fr) 1989-10-06
GB2216796B (en) 1991-07-24
AR240400A1 (es) 1990-04-30
GB8907366D0 (en) 1989-05-17
NZ228559A (en) 1990-11-27
DE3910743A1 (de) 1989-10-12
HUT49486A (en) 1989-10-30
FR2629346B1 (fr) 1991-03-29
DK158689D0 (da) 1989-03-31
JPH01305035A (ja) 1989-12-08
US5120711A (en) 1992-06-09
GB2216796A (en) 1989-10-18

Similar Documents

Publication Publication Date Title
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
EP0065513B1 (fr) Compositions pharmaceutiques antimycotiques synergiques et leur procede de preparation
HUT67436A (en) Process to prepare novel hydroxamic acid and n-hydroxyurea derivatives and pharmaceutical compn.s contg. them
PT84218A (en) Process for the preparation of 5,6-dihydro-2-(substituted phenyl) 1,2,4-triazine-3,5(2h,4h)-diones and pharmaceutical compositions therewith
DZ1766A1 (fr) Inhibiteurs de vih protéase utiles pour le traitement du sida.
NO302414B1 (no) Analogifremgangsmåte for fremstilling av heterocykliske forbindelser
BE1003046A3 (fr) Compositions veterinaires synergiquement actives et leur procede de preparation.
ES2052015T3 (es) Un metodo de preparacion de una composicion farmaceutica.
IL85945A0 (en) Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation
PT77226A (fr) Procede pour preparer derives d'acides omega-amines et compositions contenant ces derives
DZ1324A1 (fr) Dérivés de céphalosporine, procédé pour leur préparation compositions pharmaceutiques les contenant et leur utilisation dans le traitement d'infections bactériennes.
FR2455600A1 (fr) Nouvelles 2-(2,2-diphenylethyl)-quinuclidines, utiles notamment comme agents anti-diarrheiques et leur procede de preparation
ES8307820A1 (es) Procedimiento para la obtencion de esteres del acido 7b-2-(2amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido-3-cefem-4-carboxilico.
MA26744A1 (fr) Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant
OA09446A (fr) "Dérivés di-substitués des N, N-ditriméthoxybenzoyle pipérazines, un procédé pour leur préparation et compositions thérapeutiques en contenant".
OA09201A (fr) "Dérivés sulfonyles de la thiéno-triazolo-diazépine, un procédé pour leur préparation et des compositions thérapeutiques en contenant".
OA08099A (fr) Compositions et procédé pour protéger les lymphocytes T contre l'agent étiologique des lymphadénopathies et du syndrome d'immunodépression acquise.
FR2354995A1 (fr) Derives d'acide proponyl-oxamique, leur procede de preparation et leur application pour le traitement des etats allergiques chez les mammiferes
BE902010A (fr) Nouvelles combinaisons de medicaments ayant un effet synergique et procede pour les preparer.
PT81217A (fr) Process pour la preparation d'une nouvelle association contraceptive a effet synergique
FR2401132A1 (fr) Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant
NO179838C (no) Fremgangsmåte for fremstilling av S-(-)-3-morfolino-4-(3-tert-butylamino-2-hydroksypropoksy)-1,2,5-tiadiazol-hemihydrat
DE3363450D1 (en) Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them
KR890014560A (ko) 세팔로스포린 유도체 및 이의 제조방법
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EGIS GYOGYSZERGYAR

Effective date: 19960331